JPRN-UMIN000047039
Recruiting
未知
Evaluation of the accuracy of diagnosis by simple scoring system for SNADET - Evaluation of the accuracy of diagnosis by simple scoring system for SNADET
TT Medical Center Tokyo0 sites1,000 target enrollmentFebruary 28, 2022
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- TT Medical Center Tokyo
- Enrollment
- 1000
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Pathological diagnosis after endoscopic treatment was not adenoma or cancer. Endoscopic diagnosis using simple scoring system was not performed.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Retrospective study of the diagnostic accuracy of CT scan in evaluation of resectability of Boderline resectable pancareatic cancer after neoadjuvant S-1 and concurrent radiotherapyBorderline resectable pancreatic cancerJPRN-UMIN000029166ational Cancer Centor Japan53
Active, not recruiting
Phase 1
A clinical study in men with prostate cancer undergoing surgery to assess the accuracy of 99mTc-MIP-1404 imaging as compared to pathology resultsProstate Cancer within prostate gland and metastatic prostate cancer in regional lymph nodesMedDRA version: 14.1Level: LLTClassification code 10007113Term: Cancer of prostateSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2012-001864-30-BEMolecular Insight Pharmaceuticals, Inc100
Active, not recruiting
Not Applicable
Phase 2 study to assess the effectiviness of the investigational drug 99mTc-MIP-1404 in detecting prostate cancer tissue within the prostate gland and elsewhere in human body.Prostate Cancer within prostate gland and metastatic prostate cancer in regional lymph nodesMedDRA version: 15.0Level: LLTClassification code 10007113Term: Cancer of prostateSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2012-001864-30-HUMolecular Insight Pharmaceuticals, Inc100
Active, not recruiting
Phase 1
Phase 2 study to assess the effectiviness of the investigational drug 99mTc-MIP-1404 in detecting prostate cancer tissue within the prostate gland and elsewhere in human body.Prostate Cancer within prostate gland and metastatic prostate cancer in regional lymph nodesMedDRA version: 14.1Level: LLTClassification code 10007113Term: Cancer of prostateSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2012-001864-30-CZMolecular Insight Pharmaceuticals, Inc100
Active, not recruiting
Not Applicable
A clinical study in men with prostate cancer undergoing surgery to assess the accuracy of 99mTc-MIP-1404 imaging as compared to pathology resultsProstate Cancer within prostate gland and metastatic prostate cancer in regional lymph nodesMedDRA version: 14.1Level: LLTClassification code 10007113Term: Cancer of prostateSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2012-001864-30-NLMolecular Insight Pharmaceuticals, Inc100